Compounds > lomefloxacin

lomefloxacin and clinafloxacin

lomefloxacin has been researched along with clinafloxacin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG1
Blaskovich, MAT; Pham, TDM; Ziora, ZM1
Erwin, ME; Jones, RN1
Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA1
Furuhama, K; Itoh, S; Katoh, M1
Gross-Tholl, N; Herbold, B; von Keutz, E; Wirnitzer, U1
Jastrzębska, A; Kornacka, J; Nałęcz-Jawecki, G; Parzonko, A; Sommer, S; Zgadzaj, A1

Reviews

1 review(s) available for lomefloxacin and clinafloxacin

ArticleYear
Quinolone antibiotics.
    MedChemComm, 2019, Oct-01, Volume: 10, Issue:10

    Topics:

2019

Other Studies

6 other study(ies) available for lomefloxacin and clinafloxacin

ArticleYear
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1991
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
    Journal of clinical microbiology, 1992, Volume: 30, Issue:5

    Topics: Agar; Anti-Infective Agents; Drug Stability; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones

1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
    Journal of clinical microbiology, 1992, Volume: 30, Issue:5

    Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones

1992
In vivo photochemical micronucleus induction due to certain quinolone antimicrobial agents in the skin of hairless mice.
    Mutation research, 2002, Sep-26, Volume: 520, Issue:1-2

    Topics: Animals; Anti-Infective Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Fluoroquinolones; Levofloxacin; Light; Male; Mice; Mice, Hairless; Micronuclei, Chromosome-Defective; Micronucleus Tests; Ofloxacin; Photosensitizing Agents; Quinolones; Skin; Time Factors

2002
Photo-chemically induced DNA effects in the comet assay with epidermal cells of SKH-1 mice after a single oral administration of different fluoroquinolones and 8-methoxypsoralen in combination with exposure to UVA.
    Mutation research, 2006, Oct-10, Volume: 609, Issue:1

    Topics: Administration, Oral; Animals; Cells, Cultured; Ciprofloxacin; Comet Assay; DNA; DNA Damage; Epidermal Cells; Epidermis; Fluoroquinolones; Male; Methoxsalen; Mice; Mice, Hairless; Quinolones; Ultraviolet Rays

2006
Development of photoprotective, antiphototoxic, and antiphotogenotoxic formulations of ocular drugs with fluoroquinolones.
    Journal of photochemistry and photobiology. B, Biology, 2018, Volume: 178

    Topics: Animals; Cell Line; Cell Survival; Coumaric Acids; Cricetinae; Cricetulus; DNA Damage; Drug Compounding; Fleroxacin; Fluoroquinolones; Micronucleus Tests; Photolysis; Propionates; Protective Agents; Salmonella typhimurium; Ultraviolet Rays

2018